Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income Net of Income Taxes
Total
Balance at Dec. 31, 2022 $ 165 $ (796) $ 756,299 $ 127,517 $ (6,326) $ 876,859
Balance (in shares) at Dec. 31, 2022 165,448 31        
Foreign currency translation adjustment         1,193 1,193
Shares repurchased for settlement of employee tax withholdings   $ (787)       (787)
Shares repurchased for settlement of employee tax withholdings (in shares)   30        
Stock-based compensation expense     11,992     11,992
Common stock issued upon exercise of stock options $ 1   1,765     1,766
Common stock issued upon exercise of stock options (in shares) 527          
Common stock issued upon vesting of restricted stock units (in shares) 182          
Treasury stock reissued upon settlement of equity awards   $ 914 (914)      
Treasury stock reissued upon settlement of equity awards (in shares)   (35)        
Net income       12,175   12,175
Balance at Mar. 31, 2023 $ 166 $ (669) 769,142 139,692 (5,133) 903,198
Balance (in shares) at Mar. 31, 2023 166,157 26        
Balance at Dec. 31, 2022 $ 165 $ (796) 756,299 127,517 (6,326) 876,859
Balance (in shares) at Dec. 31, 2022 165,448 31        
Foreign currency translation adjustment           816
Net income           25,014
Balance at Jun. 30, 2023 $ 167 $ (528) 787,562 152,531 (5,510) 934,222
Balance (in shares) at Jun. 30, 2023 167,250 16        
Balance at Mar. 31, 2023 $ 166 $ (669) 769,142 139,692 (5,133) 903,198
Balance (in shares) at Mar. 31, 2023 166,157 26        
Foreign currency translation adjustment         (377) (377)
Shares repurchased for settlement of employee tax withholdings   $ (1,966)       (1,966)
Shares repurchased for settlement of employee tax withholdings (in shares)   57        
Stock-based compensation expense     15,399     15,399
Common stock issued upon exercise of stock options $ 1   3,990     3,991
Common stock issued upon exercise of stock options (in shares) 711          
Common stock issued upon vesting of restricted stock units (in shares) 333          
Treasury stock reissued upon settlement of equity awards   $ 2,107 (2,107)      
Treasury stock reissued upon settlement of equity awards (in shares)   (67)        
Common stock issued under employee purchase plan     1,138     1,138
Common stock issued under employee purchase plan (in shares) 49          
Net income       12,839   12,839
Balance at Jun. 30, 2023 $ 167 $ (528) 787,562 152,531 (5,510) 934,222
Balance (in shares) at Jun. 30, 2023 167,250 16        
Balance at Dec. 31, 2023 $ 171 $ (743) 878,331 198,983 (2,803) 1,073,939
Balance (in shares) at Dec. 31, 2023 171,168 22        
Foreign currency translation adjustment         (4,625) (4,625)
Shares repurchased for settlement of employee tax withholdings   $ (1,792)       (1,792)
Shares repurchased for settlement of employee tax withholdings (in shares)   48        
Stock-based compensation expense     20,718     20,718
Common stock issued upon exercise of stock options     1,695     1,695
Common stock issued upon exercise of stock options (in shares) 153          
Common stock issued upon vesting of restricted stock units $ 1   (1)      
Common stock issued upon vesting of restricted stock units (in shares) 435          
Treasury stock reissued upon settlement of equity awards   $ 1,389 (1,389)      
Treasury stock reissued upon settlement of equity awards (in shares)   (38)        
Net income       7,156   7,156
Balance at Mar. 31, 2024 $ 172 $ (1,146) 899,354 206,139 (7,428) 1,097,091
Balance (in shares) at Mar. 31, 2024 171,756 32        
Balance at Dec. 31, 2023 $ 171 $ (743) 878,331 198,983 (2,803) 1,073,939
Balance (in shares) at Dec. 31, 2023 171,168 22        
Foreign currency translation adjustment           $ (6,439)
Common stock issued upon exercise of stock options (in shares)           363
Net income           $ 14,630
Balance at Jun. 30, 2024 $ 173 $ (25,443) 926,062 213,613 (9,242) 1,105,163
Balance (in shares) at Jun. 30, 2024 172,634 1,390        
Balance at Mar. 31, 2024 $ 172 $ (1,146) 899,354 206,139 (7,428) 1,097,091
Balance (in shares) at Mar. 31, 2024 171,756 32        
Foreign currency translation adjustment         (1,814) (1,814)
Shares repurchased for settlement of employee tax withholdings   $ (660)       (660)
Shares repurchased for settlement of employee tax withholdings (in shares)   30        
Stock-based compensation expense     25,315     25,315
Common stock issued upon exercise of stock options     870     870
Common stock issued upon exercise of stock options (in shares) 126          
Common stock issued upon vesting of restricted stock units $ 1   (1)      
Common stock issued upon vesting of restricted stock units (in shares) 628          
Shares repurchased under the Repurchase Program   $ 25,027       25,027
Share repurchase program, shares repurchased   1,369        
Treasury stock reissued upon settlement of equity awards   $ 1,390 (1,390)      
Treasury stock reissued upon settlement of equity awards (in shares)   (41)        
Common stock issued under employee purchase plan     1,914     1,914
Common stock issued under employee purchase plan (in shares) 124          
Net income       7,474   7,474
Balance at Jun. 30, 2024 $ 173 $ (25,443) $ 926,062 $ 213,613 $ (9,242) $ 1,105,163
Balance (in shares) at Jun. 30, 2024 172,634 1,390